Cargando…

Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation

BACKGROUND: Dyslipidemia may be an important modifiable risk factor contributing to the increased cardiovascular risk in inflammatory bowel disease (IBD). The lipid metabolism is subject to both systemic inflammation and drug therapy; however, it is unclear if this effect is drug-class dependent. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sleutjes, Jasmijn A M, Roeters van Lennep, Jeanine E, van der Woude, C Janneke, de Vries, Annemarie C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069657/ https://www.ncbi.nlm.nih.gov/pubmed/35590447 http://dx.doi.org/10.1093/ibd/izac100

Ejemplares similares

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Inflammatory bowel disease negatively impacts household and family life
por: Paulides, Emma, et al.
Publicado: (2021)

Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease
por: Paulides, Emma, et al.
Publicado: (2021)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
por: Lie, Mitchell R. K. L., et al.
Publicado: (2018)

Integration of sex and gender in cardiovascular medicine: a scientific and clinical imperative
por: Kavousi, Maryam, et al.
Publicado: (2023)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
por: van der Giessen, Janine, et al.
Publicado: (2019)

The impact of biologics on health-related quality of life in patients with inflammatory bowel disease
por: Vogelaar, Lauran, et al.
Publicado: (2009)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: van de Pol, Natasja, et al.
Publicado: (2023)

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
por: Pauwels, Renske W M, et al.
Publicado: (2021)

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
por: Pauwels, Renske W. M., et al.
Publicado: (2020)

Impact of timing of primary ileocecal resection on prognosis in patients with Crohn’s disease
por: Beelen, Evelien M J, et al.
Publicado: (2023)

Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy
por: Benschop, Laura, et al.
Publicado: (2019)

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models
por: van der Giessen, Janine, et al.
Publicado: (2019)

Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
por: Lie, Mitchell R. K. L., et al.
Publicado: (2020)

Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study
por: van den Brink, Gertrude, et al.
Publicado: (2019)

Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
por: Al Dubayee, Mohammed, et al.
Publicado: (2022)

Intestinal resection rates in Crohn’s disease decline across two different epidemiological areas: a consistent observation not merely due to introduction of anti-TNFα
por: Beelen, Evelien M J, et al.
Publicado: (2020)

Maternal lipid profile in pregnancy and embryonic size: a population-based prospective cohort study
por: Gootjes, Dionne V., et al.
Publicado: (2022)

Gestational lipid profile as an early marker of metabolic syndrome in later life: a population-based prospective cohort study
por: Adank, Maria C., et al.
Publicado: (2020)

Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease
por: van Linschoten, Reinier Cornelis Anthonius, et al.
Publicado: (2023)

Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters
por: Vogelaar, Lauran, et al.
Publicado: (2017)

Maternal lipid levels in early pregnancy as a predictor of childhood lipid levels: a prospective cohort study
por: Adank, Maria C., et al.
Publicado: (2022)

Aging, Cardiovascular Risk, and SHBG Levels in Men and Women From the General Population
por: Aribas, Elif, et al.
Publicado: (2021)

Adverse Events Associated With PCSK9 Inhibitors: A Real‐World Experience
por: Gürgöze, Muhammed T., et al.
Publicado: (2018)

Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice
por: Pauwels, Renske Wilhelmina Maria, et al.
Publicado: (2020)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019)

Maternal lipid profile in early pregnancy is associated with foetal growth and the risk of a child born large-for-gestational age: a population-based prospective cohort study: Maternal lipid profile in early pregnancy and foetal growth
por: Adank, Maria C., et al.
Publicado: (2020)

Effects of menstruation on the onset of acute coronary syndrome in premenopausal women: A case series
por: van der Bijl, Marte F., et al.
Publicado: (2023)

Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents
por: van Linschoten, Reinier Cornelis Anthonius, et al.
Publicado: (2021)

Cardiac medication use in patients with suspected ischaemia without obstructive coronary arteries: sex differences and psychological distress
por: Mommersteeg, P. M. C., et al.
Publicado: (2021)

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
por: Deuring, J. Jasper, et al.
Publicado: (2019)

Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey
por: Baars, J. E., et al.
Publicado: (2012)

Catamenial chest pain and spontaneous coronary artery dissection: A case report
por: Al Fatly, Zainab, et al.
Publicado: (2020)

Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
por: Bots, Sophie H., et al.
Publicado: (2022)

Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when
por: Groenhof, T Katrien J, et al.
Publicado: (2017)

The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
por: Schreuder, Michelle M., et al.
Publicado: (2021)

Local Immune Regulation of Mucosal Inflammation by Tacrolimus
por: van Dieren, Jolanda M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5qad5bgk4aus8codc782kr48fc